000 | 01078 a2200277 4500 | ||
---|---|---|---|
005 | 20250517230558.0 | ||
264 | 0 | _c20190506 | |
008 | 201905s 0 0 eng d | ||
022 | _a1945-7197 | ||
024 | 7 |
_a10.1210/jc.2018-01094 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTurnbull, Clare | |
245 | 0 | 0 |
_aResponse to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _c09 2018 |
||
300 |
_a3518-3519 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-ret _xgenetics |
650 | 0 | 4 | _aThyroid Neoplasms |
700 | 1 | _aLoveday, Chey | |
700 | 1 | _aIzatt, Louise | |
700 | 1 | _aEllard, Sian | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 103 _gno. 9 _gp. 3518-3519 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2018-01094 _zAvailable from publisher's website |
999 |
_c28655936 _d28655936 |